GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Xizang Weixinkang Pharmaceutical Co Ltd (SHSE:603676) » Definitions » Total Long-Term Liabilities

Xizang Weixinkang Pharmaceutical Co (SHSE:603676) Total Long-Term Liabilities : ¥40 Mil (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Xizang Weixinkang Pharmaceutical Co Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Xizang Weixinkang Pharmaceutical Co's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was ¥40 Mil.

Xizang Weixinkang Pharmaceutical Co Total Long-Term Liabilities Historical Data

The historical data trend for Xizang Weixinkang Pharmaceutical Co's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xizang Weixinkang Pharmaceutical Co Total Long-Term Liabilities Chart

Xizang Weixinkang Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.88 9.05 33.04 41.76 41.07

Xizang Weixinkang Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.63 43.85 44.52 41.07 40.35

Xizang Weixinkang Pharmaceutical Co Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Xizang Weixinkang Pharmaceutical Co Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Xizang Weixinkang Pharmaceutical Co's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Xizang Weixinkang Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Xizang Weixinkang Pharmaceutical Co Ltd (SHSE:603676) » Definitions » Total Long-Term Liabilities
Comparable Companies
SZSE:002793 SHSE:688176 SHSE:603207 SZSE:002900 SHSE:603439 SZSE:300194 SZSE:300436 SZSE:301211 SZSE:300485 SZSE:002688 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
Yuanqu South Road, 3rd Floor, Building 4, Industrial Center, No. 5, Zone B, Lhasa Economic and Technological, Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000
Website
https://www.wxkpharma.com
Xizang Weixinkang Pharmaceutical Co Ltd is engaged in research & development, production and sales of chemical pharmaceutical preparations and their raw materials. It also produces and sells liver protection drugs and antibiotic products.
Executives
Weng Zi Zhong senior management
Chen Shi Gong Directors, senior managers
Zhou Xiao Bing senior management
Liu Feng Directors, senior managers
Yu Hai Bo senior management
Zhang Hong Directors, senior managers
Zheng Yan Xia senior management
Wen Xiao Quan Director

Xizang Weixinkang Pharmaceutical Co Headlines

No Headlines